Natera, Inc. (NTRA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 88.61 |
| Open | 89.44 |
| Bid | 90.99 x 400 |
| Ask | 91.08 x 400 |
| Day's Range | 89.44 - 93.05 |
| 52 Week Range | 36.90 - 98.82 |
| Volume | |
| Avg. Volume | 1,429,135 |
| Market Cap | 10.994B |
| Beta (5Y Monthly) | 1.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.78 |
| Earnings Date | May 07, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 103.94 |
GuruFocus.comInsider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), has sold 1,523 shares of the company on April 23, 2024, according to a recent SEC filing.
GuruFocus.comCEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 2,552 shares of the company on April 23, 2024, according to a recent SEC Filing.
Business WireNatera Announces Significant Milestone with 200+ Peer-Reviewed Publications
AUSTIN, Texas, April 22, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that it has passed a significant milestone with the publication of more than 200 peer-reviewed papers highlighting Natera’s technology in the scientific literature.
© 2024 Yahoo. All rights reserved.